Compare Dicks Sporting Goods Inc (DKS) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dicks Sporting Goods Inc vs GeneDx Holdings Corp — how do they compare? Dicks Sporting Goods Inc trades at $136.65 (market cap $13.26B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Dicks Sporting Goods Inc is far larger — about 6.6× GeneDx Holdings Corp's market cap, and Dicks Sporting Goods Inc pays a 3.71% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dicks Sporting Goods Inc for 19 Days and GeneDx Holdings Corp for 19 Days on average.
| DKS | WGS | |
|---|---|---|
Market Cap | $13.26B | $2.02B |
Volume | 2,292,035 | 734,640 |
Sector | Consumer Cyclical | Health |
52-Week High | $239.17 | $167.51 |
52-Week Low | $121.15 | $34.51 |
Typical Hold Time | 19 Days | 19 Days |
Enterprise Value | $20.31B | $2.05B |
Dividend Yield | 3.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DICK'S Sporting Goods (DKS) trades at $136.65, up 4.17% today, with a bearish technical signal but strong fundamentals including a P/E of 14.86 and ROE of 18.47%. Recent earnings show mixed results, with Q2 2026 missing estimates, while Q3 2026 results are pending. The company faces a securities class action lawsuit, with multiple law firms alerting investors of a November 2026 deadline, contributing to negative sentiment despite a dividend announcement of $1.25 payable in September 2026.
The outlook is cautious due to legal overhangs and a bearish technical trend, but valuation metrics remain attractive. Upside exists if the company exceeds Q3 earnings expectations and resolves legal issues. Key risks include the class action lawsuit, competitive pressures, and potential margin compression from increased investing activities. Analyst consensus is bullish with a $153.30 price target, suggesting 12% upside from current levels.
GeneDx (WGS) trades at $67.33, down 1.75% today, with a mixed technical picture showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 revenue of $114.4M, beating expectations with a return to adjusted profitability, though full-year 2026 shows negative net margins. Recent news highlights product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus is strongly bullish with an $81 price target, fundamental risks remain due to negative profitability and high valuation multiples. The stock offers potential upside if operational improvements continue, but investors face execution risk amid ongoing losses and competitive pressures in the genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dicks Sporting Goods Inc
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
